Sangeeta N. Bhatia insider trades

Open-market stock purchases and sales by Sangeeta N. Bhatia, Director at Vertex Pharmaceuticals Inc / MA, from SEC Form 4 filings since Jun 4, 2015.

Recent trades

DateStockTradeValue
May 4, 2026VRTX Vertex Pharmaceuticals Inc / MASold$135K
May 1, 2026VRTX Vertex Pharmaceuticals Inc / MABought (not open market)—
Feb 13, 2026VRTX Vertex Pharmaceuticals Inc / MASold$133K

Companies traded

  • VRTX Vertex Pharmaceuticals Inc / MA: 59 sales, last May 4, 2026

Get free alerts when Sangeeta N. Bhatia files a new trade →